A detailed history of Advantage Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Advantage Trust CO holds 610 shares of BDX stock, worth $139,153. This represents 0.1% of its overall portfolio holdings.

Number of Shares
610
Previous 400 52.5%
Holding current value
$139,153
Previous $93.5 Million 57.32%
% of portfolio
0.1%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$221.47 - $242.41 $46,508 - $50,906
210 Added 52.5%
610 $147 Million
Q4 2023

Feb 07, 2024

BUY
$232.24 - $267.23 $92,896 - $106,892
400 New
400 $97.5 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Advantage Trust CO Portfolio

Follow Advantage Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Trust CO with notifications on news.